Nifty
:
14521.15
Sensex
:
49398.29
239.85 (1.68%)
834.02 (1.72%)
Nifty
Sensex
:
:
14521.15
49398.29
239.85 (1.68%)
834.02 (1.72%)

Emami Ltd.

Household & Personal Products

Rating :
60/99

BSE: 531162 | NSE: EMAMILTD

NSE BSE
481.35
19-Jan-2021
  • Open
  • High
  • Low
  • Previous Close
  •  480.90
  •  493.20
  •  475.00
  •  480.90
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  695013
  •  3351.16
  •  501.10
  •  130.95

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 21,209.97
  • 65.61
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 21,467.84
  • 0.83%
  • 12.03

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 53.86%
  • 3.67%
  • 4.90%
  • FII
  • DII
  • Others
  • 9.62%
  • 23.27%
  • 4.68%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.85
  • 2.40
  • 1.61

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.86
  • 2.10
  • 1.44

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 3.05
  • -3.20
  • 0.06

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 51.72
  • 62.48
  • 54.01

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 12.73
  • 11.45
  • 8.81

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 26.94
  • 27.05
  • 22.79

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Net Sales
734.82
660.05
11.33%
481.34
648.64
-25.79%
532.68
640.35
-16.81%
812.64
811.09
0.19%
Expenses
477.73
467.07
2.28%
358.36
514.50
-30.35%
434.15
484.92
-10.47%
548.62
547.67
0.17%
EBITDA
257.09
192.98
33.22%
122.98
134.14
-8.32%
98.53
155.43
-36.61%
264.02
263.42
0.23%
EBIDTM
34.99%
29.24%
25.55%
20.68%
14.01%
14.01%
32.49%
32.48%
Other Income
7.89
16.38
-51.83%
6.70
11.49
-41.69%
14.49
16.55
-12.45%
15.58
8.74
78.26%
Interest
2.48
9.32
-73.39%
4.70
4.35
8.05%
2.41
6.21
-61.19%
4.93
6.23
-20.87%
Depreciation
114.83
81.87
40.26%
74.79
83.67
-10.61%
85.24
81.00
5.23%
85.55
79.21
8.00%
PBT
147.67
118.17
24.96%
50.19
57.61
-12.88%
17.95
84.77
-78.83%
185.86
176.92
5.05%
Tax
28.40
21.13
34.41%
9.48
17.69
-46.41%
-7.37
27.98
-
39.82
38.62
3.11%
PAT
119.27
97.04
22.91%
40.71
39.92
1.98%
25.32
56.79
-55.41%
146.04
138.30
5.60%
PATM
16.23%
14.70%
8.46%
6.15%
7.11%
7.11%
17.97%
17.05%
EPS
2.66
2.12
25.47%
0.89
0.86
3.49%
28.29
28.29
0.00%
3.18
3.03
4.95%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
2,561.48
2,654.88
2,694.63
2,530.55
2,488.17
2,358.35
2,217.25
1,820.77
1,699.10
1,453.51
1,247.07
Net Sales Growth
-7.20%
-1.48%
6.48%
1.70%
5.50%
6.36%
21.78%
7.16%
16.90%
16.55%
 
Cost Of Goods Sold
5,282.11
876.09
923.01
809.85
791.00
812.13
779.96
680.28
715.45
556.86
467.55
Gross Profit
-2,720.63
1,778.78
1,771.62
1,720.70
1,697.17
1,546.22
1,437.28
1,140.49
983.65
896.65
779.52
GP Margin
-106.21%
67.00%
65.75%
68.00%
68.21%
65.56%
64.82%
62.64%
57.89%
61.69%
62.51%
Total Expenditure
1,818.86
1,964.33
1,967.41
1,887.71
1,786.88
1,735.82
1,767.76
1,387.27
1,255.46
1,072.60
891.55
Power & Fuel Cost
-
22.47
22.64
18.32
15.19
12.18
12.48
9.79
8.67
6.97
6.09
% Of Sales
-
0.85%
0.84%
0.72%
0.61%
0.52%
0.56%
0.54%
0.51%
0.48%
0.49%
Employee Cost
-
299.51
279.72
254.65
233.55
207.80
167.13
139.01
115.55
92.31
72.87
% Of Sales
-
11.28%
10.38%
10.06%
9.39%
8.81%
7.54%
7.63%
6.80%
6.35%
5.84%
Manufacturing Exp.
-
96.77
83.51
32.58
32.27
24.39
20.17
20.70
16.18
83.07
67.37
% Of Sales
-
3.64%
3.10%
1.29%
1.30%
1.03%
0.91%
1.14%
0.95%
5.72%
5.40%
General & Admin Exp.
-
82.59
75.65
109.63
101.79
73.50
66.23
48.76
44.17
40.39
39.93
% Of Sales
-
3.11%
2.81%
4.33%
4.09%
3.12%
2.99%
2.68%
2.60%
2.78%
3.20%
Selling & Distn. Exp.
-
540.94
542.54
542.07
515.54
501.90
600.02
455.90
433.13
360.96
319.03
% Of Sales
-
20.38%
20.13%
21.42%
20.72%
21.28%
27.06%
25.04%
25.49%
24.83%
25.58%
Miscellaneous Exp.
-
45.96
40.34
120.62
97.55
103.92
121.77
32.81
24.40
34.12
319.03
% Of Sales
-
1.73%
1.50%
4.77%
3.92%
4.41%
5.49%
1.80%
1.44%
2.35%
1.67%
EBITDA
742.62
690.55
727.22
642.84
701.29
622.53
449.49
433.50
443.64
380.91
355.52
EBITDA Margin
28.99%
26.01%
26.99%
25.40%
28.18%
26.40%
20.27%
23.81%
26.11%
26.21%
28.51%
Other Income
44.66
57.07
34.90
96.10
88.93
109.20
182.41
73.07
55.68
54.12
44.91
Interest
14.52
21.01
21.40
34.31
58.01
54.03
5.14
5.38
6.57
15.21
15.23
Depreciation
360.41
336.33
325.31
310.86
308.58
254.93
34.31
35.17
124.06
120.89
116.09
PBT
401.67
390.28
415.41
393.77
423.62
422.77
592.44
466.02
368.68
298.94
269.12
Tax
70.33
71.27
100.88
86.26
83.62
59.71
107.00
54.70
54.00
40.12
40.41
Tax Rate
17.51%
18.78%
24.87%
21.91%
19.74%
14.12%
18.06%
11.97%
14.65%
13.42%
15.02%
PAT
331.34
308.93
305.43
308.35
340.42
363.53
485.61
402.47
314.74
258.84
228.72
PAT before Minority Interest
331.33
308.32
304.73
307.51
340.01
363.06
485.45
402.43
314.68
258.81
228.71
Minority Interest
-0.01
0.61
0.70
0.84
0.41
0.47
0.16
0.04
0.06
0.03
0.01
PAT Margin
12.94%
11.64%
11.33%
12.19%
13.68%
15.41%
21.90%
22.10%
18.52%
17.81%
18.34%
PAT Growth
-0.21%
1.15%
-0.95%
-9.42%
-6.36%
-25.14%
20.66%
27.87%
21.60%
13.17%
 
EPS
7.45
6.95
6.87
6.94
7.66
8.18
10.92
9.05
7.08
5.82
5.15

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
1,823.75
2,076.06
2,013.61
1,754.69
1,611.61
1,230.64
932.12
777.47
706.63
689.85
Share Capital
45.32
45.39
22.70
22.70
22.70
22.70
22.70
15.13
15.13
15.13
Total Reserves
1,778.43
2,030.67
1,990.91
1,732.00
1,588.91
1,207.94
909.42
762.34
691.50
674.72
Non-Current Liabilities
63.55
62.72
69.73
64.87
341.83
54.59
51.22
58.06
78.65
94.86
Secured Loans
0.00
0.00
0.00
0.00
0.00
1.71
17.45
28.17
52.68
69.65
Unsecured Loans
0.00
0.00
0.00
0.00
300.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
23.10
19.95
23.83
23.88
18.99
24.53
17.13
7.37
3.89
3.81
Current Liabilities
792.04
679.94
713.94
782.19
734.68
386.53
318.93
524.36
496.10
404.10
Trade Payables
324.46
291.36
242.03
184.70
248.72
193.23
142.97
102.00
104.54
69.49
Other Current Liabilities
100.62
157.11
81.96
361.07
64.57
62.01
50.45
56.34
73.61
62.17
Short Term Borrowings
210.23
109.87
325.91
172.96
371.44
17.70
4.37
57.56
55.55
112.08
Short Term Provisions
156.73
121.61
64.03
63.46
49.95
113.59
121.14
308.46
262.40
160.35
Total Liabilities
2,678.48
2,818.52
2,797.85
2,603.16
2,692.22
1,676.32
1,302.28
1,359.94
1,281.50
1,188.88
Net Block
1,404.72
1,625.29
1,746.17
1,939.94
1,917.51
452.90
395.86
396.79
407.70
485.22
Gross Block
2,929.52
2,815.07
2,619.10
2,499.48
2,354.84
641.10
1,035.97
944.02
841.90
800.06
Accumulated Depreciation
1,524.80
1,189.79
872.93
559.53
437.32
188.19
640.11
547.23
434.20
314.83
Non Current Assets
1,645.16
1,969.19
2,097.09
2,162.24
2,186.94
532.83
456.58
485.17
519.31
551.81
Capital Work in Progress
8.05
36.33
30.47
21.52
67.09
28.77
11.91
47.46
76.81
6.48
Non Current Investment
142.54
233.90
241.42
148.20
92.00
6.61
6.62
6.78
6.77
6.61
Long Term Loans & Adv.
47.79
44.31
51.79
43.57
110.34
44.55
42.20
34.15
24.58
50.12
Other Non Current Assets
42.06
29.36
27.24
9.00
0.00
0.00
0.00
0.00
3.45
3.38
Current Assets
1,033.32
849.33
700.76
440.92
505.28
1,143.49
845.71
874.77
762.19
637.07
Current Investments
68.33
7.86
128.06
33.32
11.93
494.65
289.22
156.34
73.56
0.00
Inventories
244.65
221.73
193.95
179.16
150.53
126.65
141.15
113.98
112.20
123.36
Sundry Debtors
308.01
216.35
155.89
97.01
130.88
101.77
79.29
112.22
100.54
108.71
Cash & Bank
119.06
203.41
79.52
50.05
108.43
354.11
269.96
281.71
275.94
210.50
Other Current Assets
293.28
55.57
60.55
8.85
103.50
66.31
66.07
210.51
199.95
194.51
Short Term Loans & Adv.
196.18
144.41
82.78
72.52
90.75
58.40
57.94
203.44
191.61
166.63
Net Current Assets
241.28
169.39
-13.18
-341.27
-229.40
756.96
526.77
350.41
266.08
232.98
Total Assets
2,678.48
2,818.52
2,797.85
2,603.16
2,692.22
1,676.32
1,302.29
1,359.94
1,281.50
1,188.88

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
530.75
553.74
587.81
729.63
561.62
534.05
428.22
322.95
360.45
126.52
PBT
373.57
403.41
393.77
423.62
422.77
592.44
466.02
368.68
298.94
269.12
Adjustment
313.18
316.97
336.18
354.15
291.05
-36.34
-16.52
-8.54
18.23
13.67
Changes in Working Capital
-80.02
-73.93
-61.24
22.56
-56.47
73.51
59.56
12.92
69.98
-123.63
Cash after chg. in Working capital
606.73
646.46
668.71
800.34
657.35
629.62
509.06
373.06
387.14
159.16
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-75.98
-92.72
-80.90
-70.72
-95.73
-95.57
-76.56
-50.12
-26.69
-32.64
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
-4.28
0.00
0.00
0.00
Cash From Investing Activity
-227.69
-23.39
-279.12
-297.48
-1,306.43
-233.70
-141.87
-123.64
-132.65
37.04
Net Fixed Assets
-73.95
-199.44
-121.64
-100.48
-1,751.69
387.80
-52.06
-64.24
-96.89
-33.77
Net Investments
27.04
129.78
-189.36
-77.95
406.63
-205.42
-132.73
-82.78
-73.72
55.00
Others
-180.78
46.27
31.88
-119.05
38.63
-416.08
42.92
23.38
37.96
15.81
Cash from Financing Activity
-405.36
-427.66
-323.74
-495.82
501.82
-215.39
-301.30
-188.47
-144.93
-102.24
Net Cash Inflow / Outflow
-102.29
102.68
-15.05
-63.67
-243.00
84.96
-14.95
10.84
82.87
61.32
Opening Cash & Equivalents
116.47
16.19
28.40
100.51
349.75
268.03
280.85
275.94
210.50
161.43
Closing Cash & Equivalent
10.84
116.47
16.19
28.40
100.51
349.75
268.03
280.85
275.94
210.50

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
40.24
45.73
44.36
38.66
35.50
27.11
20.53
17.13
15.57
15.20
ROA
11.22%
10.85%
11.39%
12.84%
16.62%
32.60%
30.23%
23.83%
20.95%
19.88%
ROE
15.81%
14.90%
16.32%
20.20%
25.55%
44.89%
47.08%
42.41%
37.07%
34.74%
ROCE
18.99%
18.87%
18.75%
21.36%
26.87%
53.44%
49.68%
42.77%
35.37%
31.60%
Fixed Asset Turnover
0.92
0.99
0.99
1.04
1.60
2.69
1.87
1.94
1.80
1.62
Receivable days
36.05
25.21
18.17
16.45
17.71
14.64
18.85
22.39
25.84
26.55
Inventory Days
32.06
28.15
26.80
23.80
21.10
21.66
25.12
23.81
29.09
29.70
Payable days
51.32
44.28
39.14
41.21
43.84
38.14
32.52
26.43
26.35
26.77
Cash Conversion Cycle
16.78
9.09
5.83
-0.95
-5.03
-1.84
11.45
19.77
28.57
29.48
Total Debt/Equity
0.12
0.05
0.16
0.27
0.42
0.03
0.04
0.15
0.22
0.32
Interest Cover
19.07
19.95
12.48
8.30
8.82
116.24
85.93
57.13
20.65
18.67

Annual Reports:

FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014
FY 2013
FY 2012
FY 2011

News Update:


  • Emami gets WHO-GMP certification for two units at Gujarat
    23rd Dec 2020, 12:46 PM

    The two units have also obtained Certificate of Pharmaceutical Products

    Read More
  • Emami’s arm disposes entire stake in Fravin Pty
    19th Dec 2020, 10:12 AM

    Consequently, Fravin Pty and its step down subsidiary companies, namely Diamond Bio Tech Laboratories Pty and Abache Pty have ceased to be subsidiary Companies of Emami

    Read More
  • Emami targets consumers shifting to homegrown brands post ‘Aatmanirbhar’ campaign
    23rd Nov 2020, 10:21 AM

    The company is looking to become a serious player in the segment with plans to introduce more products in future

    Read More
  • Emami enters into home hygiene segment under 'Emasol' brand
    18th Nov 2020, 16:26 PM

    Its Emasol home hygiene products will be available in the price range of Rs 30 to Rs 199, depending on product and size of packs

    Read More
  • Emami bets on rural demand, sales of health & hygiene products to maintain growth in Q3
    10th Nov 2020, 09:24 AM

    'Boroplus' brand will also play a crucial role with a rise in demand for winter products in the current quarter

    Read More
  • Emami reports 23% rise in Q2 consolidated net profit
    5th Nov 2020, 15:42 PM

    Total income of the company increased by 9.80% at Rs 742.71 crore for Q2FY21

    Read More
  • Emami - Quarterly Results
    5th Nov 2020, 13:47 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.